TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.

Cynthia X Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.